Selagine Plasma to Advance Pooled Plasma Eye Drops for Moderate-to-Severe Dry Eye
Agreement with Selagine, Inc. supports the development of an investigational pooled plasma biologic platform intended to move beyond individualized compounded serum tears CHICAGO, June 9, 2026 /PRNewswire/ -- Selagine Plasma, Inc. announced that it has received certain intellectual...
View original →